Indium (111In) igovomab (trade name Indimacis-125) was a mouse monoclonal antibody for the diagnosis of ovarian cancer.[citation needed]Linked to the chelating agent DTPA and labelled with Indium-111 it was used […]
List of articles in "Drug" category - Page 360
Detumomab
Detumomab is a mouse monoclonal antibody developed for the treatment of cancer.[citation needed]
Indium (111In) capromab pendetide
Indium (111In) capromab pendetide (trade name Prostascint) is used to image the extent of prostate cancer. Capromab is a mouse monoclonal antibody which recognizes prostate specific membrane antigen (PSMA) from […]
Labetuzumab
Labetuzumab (marketed under the trade name CEA-CIDE) is a humanized IgG1 monoclonal antibody for the treatment of colorectal cancer.This drug was developed by Immunomedics Inc.
Raxibacumab
Raxibacumab is a human monoclonal antibody intended for the prophylaxis and treatment of inhaled anthrax. Its efficacy has been proven in rabbits and monkeys.
Efungumab
Efungumab (trade name Mycograb) is a drug developed by NeuTec Pharma (a subsidiary of Novartis) intended to treat invasive Candida infection in combination with amphotericin B.
Stamulumab
Stamulumab (MYO-029) is an experimental myostatin inhibiting drug developed by Wyeth Pharmaceuticals for the treatment of muscular dystrophy (MD). Stamulumab was formulated and tested by Wyeth in Collegeville Pennsylvania.
Zalutumumab
Zalutumumab (proposed trade name HuMax-EGFr) is a fully human IgG1 monoclonal antibody (mAb) directed towards the epidermal growth factor receptor (EGFr). It is a product developed by Genmab in Utrecht […]
Pritumumab
Pritumumab is a human monoclonal antibody used in the treatment of brain cancer.
Ofatumumab
Ofatumumab (trade name Arzerra also known as HuMax-CD20) is a humanized monoclonal antibody (for the CD20 protein) which appears to inhibit early-stage B lymphocyte activation. It is FDA approved for […]